Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples